Dividend Yield: 5.5%

BioGaia's recent Q2 2024 earnings showed strong growth with sales reaching SEK 384.12 million and net income rising to SEK 111.01 million, supporting its dividend sustainability despite a high cash payout ratio of 193.5%. The company is expanding its distribution in Australia and New Zealand, targeting significant market potential. While dividends have increased over the past decade, they remain volatile and are not well covered by free cash flows, though earnings coverage is reasonable at a 47.8% payout ratio.

• Unlock comprehensive insights into our analysis of BioGaia stock in this dividend report.

• Our expertly prepared valuation report BioGaia implies its share price may be lower than expected.

HEXPOL

Simply Wall St Dividend Rating: ★★★★★☆

Overview: HEXPOL AB (publ) develops, manufactures, and sells various polymer compounds and engineered products across Sweden, Europe, the Americas, and Asia with a market cap of SEK38.34 billion.

Operations: HEXPOL AB (publ) generates revenue primarily from its HEXPOL Compounding segment, which accounts for SEK20.18 billion, and its HEXPOL Engineered Products segment, contributing SEK1.61 billion.

Dividend Yield: 3.6%

HEXPOL's dividend payments are well-covered by both earnings (55.4% payout ratio) and free cash flows (57.8% cash payout ratio). The company has maintained stable and growing dividends over the past decade, although its current yield of 3.59% is lower than the top 25% of Swedish dividend payers. Recent Q2 2024 earnings showed a slight decline in sales to SEK 5.45 billion from SEK 5.73 billion year-over-year, with net income also decreasing to SEK 654 million from SEK 679 million.

• Click here to discover the nuances of HEXPOL with our detailed analytical dividend report.

• In light of our recent valuation report, it seems possible that HEXPOL is trading behind its estimated value.

Key Takeaways

• Gain an insight into the universe of 22 Top Swedish Dividend Stocks by clicking here.

• Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.

• Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.

Ready To Venture Into Other Investment Styles?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include OM:AFRY OM:BIOG B and OM:HPOL B.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]